Callio emerges with $187M and ADCs from a decade-old Singapore biotech

Frazier Life Sciences and a cadre of well-known biotech investors are coming together for a new startup in the antibody-drug conjugates field, an area of cancer treatment R&D that has remained hot. Investors are pumping ...

Mar 3, 2025 - 15:02

Callio emerges with $187M and ADCs from a decade-old Singapore biotech

Frazier Life Sciences and a cadre of well-known biotech investors are coming together for a new startup in the antibody-drug conjugates field, an area of cancer treatment R&D that has remained hot. Investors are pumping ...